------------------------------
OMB APPROVAL
OMB Number 3235-0145
Expires: August 31, 1999
Estimated average burden
hours per response ......14.90
------------------------------
================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.
----------------
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO
RULES 13d-1(b)(c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(Amendment No. __1___)(1)
Gartner Group, Inc.
------------------
(Name of Issuer)
Class A Common Stock
------------------------------
(Title of Class of Securities)
366651107
-------------
(CUSIP Number)
December 31, 1999
------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
13G is filed:
[ ] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[X] Rule 13d-1(d)
(1) The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
================================================================================
(Continued on following page(s))
Page 1 of 7 Pages
<PAGE>
SCHEDULE 13G
CUSIP NO. 366651107
- -------------------
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. ABOVE PERSON
IMS Health Incorporated 06-1506026
- -----------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
(b)
- -----------------------------------------------------------
3. SEC USE ONLY
- -----------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- -----------------------------------------------------------
5. SOLE VOTING POWER
NUMBER OF 7,391,481
SHARES -----------------------------------------
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY 117,376
EACH -----------------------------------------
REPORTING 7. SOLE DISPOSITIVE POWER
PERSON 7,391,481
WITH -----------------------------------------
8. SHARED DISPOSITIVE POWER
117,376
-----------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
7,391,481
- -----------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* ( )
- -----------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.7%
- -----------------------------------------------------------
12. TYPE OF REPORTING PERSON*
CO
- -----------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
Page 2 of 7 Pages
<PAGE>
SCHEDULE 13G
CUSIP NO. 366651107
- --------------------
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. ABOVE PERSON
IMS Health Licensing Associates, L.P. 98-0137321
- -----------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
(b)
- -----------------------------------------------------------
3. SEC USE ONLY
- -----------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- -----------------------------------------------------------
NUMBER OF 5. SOLE VOTING POWER
SHARES -0-
BENEFICIALLY -----------------------------------------
OWNED BY 6. SHARED VOTING POWER
EACH 117,376
REPORTING -----------------------------------------
PERSON 7. SOLE DISPOSITIVE POWER
WITH -0-
-----------------------------------------
8. SHARED DISPOSITIVE POWER
117,376
-----------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
117,376
- -----------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* ( )
- -----------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
0.15%
- -----------------------------------------------------------
12. TYPE OF REPORTING PERSON*
CO
- -----------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
Page 3 of 7 Pages
<PAGE>
ITEM 1 (a). NAME OF ISSUER
Gartner Group, Inc.
- -----------------------------------------------------------
ITEM 1 (b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE
OFFICES
56 Top Gallant Road, Stamford, Connecticut 06904-2212
- -----------------------------------------------------------
ITEM 2 (a). NAME OF PERSON FILING
IMS Health Incorporated ("IMS HEALTH") and its subsidiary,
IMS Health Licensing Associates, L.P. ("IMSHLA")
- ----------------------------------------------------------
ITEM 2 (b). ADDRESS OF PRINCIPAL BUSINESS OFFICE
The principal business office of IMS HEALTH is located at
200 Nyala Farms, Westport, Connecticut 06880. The principal
business office of IMSHLA is located at Dorfplatz 4, 6330
CHAM Switzerland.
- -----------------------------------------------------------
ITEM 2 (c). CITIZENSHIP
IMS HEALTH is incorporated under the laws of the State of
Delaware. IMSHLA is a limited partnership established under
the laws of the State of Delaware.
- -----------------------------------------------------------
ITEM 2 (d). TITLE OF CLASS OF SECURITIES
Class A Common Stock
- -----------------------------------------------------------
ITEM 2 (e). CUSIP NUMBER
366651107
- -----------------------------------------------------------
ITEM 3.
Not Applicable
- -----------------------------------------------------------
ITEM 4. OWNERSHIP
The following information is provided as of December
31, 1999:
(a) Amount Beneficially Owned
IMS HEALTH is the owner of record and beneficially of 6,792,081 shares of
Class A Common Stock and Warrants to purchase 599,400 shares of Class A
Common Stock. IMSHLA is the owner of record and beneficially of 117,376
shares of Class A Common Stock. With an 84.52% interest in IMSHLA, IMS
HEALTH may be deemed to be a beneficial owner of the shares held by it, for
an aggregate beneficial ownership by IMS HEALTH of 7,508,857 shares.
Page 4 of 7 Pages
<PAGE>
(b) Percent of Class:
IMS HEALTH - 9.7% (this percentage calculation assumes
the conversion of the Warrant to purchase 599,400
shares of Common Stock)
IMSHLA - 0.15%
(c) NUMBER OF SHARES AS TO WHICH IMS HEALTH, Enterprises and
IMSHLA HAVE:
(i) sole power to vote or to direct the vote:
IMS HEALTH - 7,391,481 (includes 599,400 shares
issuable pursuant to the Warrant)
IMSHLA - None
(ii) shared power to vote or to direct the vote:
IMS HEALTH - 117,376
IMSHLA - 117,376
(iii) sole power to dispose or to direct the disposition of:
IMS HEALTH - 7,391,481 (includes 599,400 shares
issuable pursuant to the Warrant)
IMSHLA - None
(iv) shared power to dispose or to direct the
disposition of:
IMS HEALTH - 117,376
IMSHLA - 117,376
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF CLASS
Not Applicable
- ------------------------------------------------------------
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF
ANOTHER PERSON
Not applicable
- ------------------------------------------------------------
Page 5 of 7 Pages
<PAGE>
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY
WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE
PARENT HOLDING COMPANY
Not applicable
- ------------------------------------------------------------
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE
GROUP
Not applicable
- ------------------------------------------------------------
ITEM 9. NOTICE OF DISSOLUTION OF GROUP
Not applicable
- ------------------------------------------------------------
ITEM 10. CERTIFICATION
Not applicable
- ------------------------------------------------------------
SIGNATURE
- ----------
After reasonable inquiry and to the best of my knowledge and belief I
certify that the information set forth in this statement is true, complete
and correct.
Dated: February 1, 2000
IMS HEALTH INCORPORATED
By /s/ MATTHEW L. FRIEDMAN
------------------------------
Name: Matthew L. Friedman
Title: Vice President and Treasurer
IMS HEALTH LICENSING ASSOCIATES, L.P.
By /s/ PETER ECSHER
-------------------------------
Peter Ecsher, on behalf of
the General Partner,
IMS Pharminform Holding, AG
Page 6 of 7 Pages
<PAGE>
AGREEMENT
Westport, CT
February 1, 2000
IMS Health Incorporated ("IMS HEALTH") and IMS Health Licensing Associates,
L.P.("IMSHLA")hereby agree to file a joint Schedule 13G under the Securities
Exchange Act of 1934 (the "Act") in connection with their beneficial ownership
of common stock issued by Gartner Group, Inc.
IMS HEALTH and IMSHLA state they are each entitled to individually use
Schedule 13G pursuant to Rule 13d-1 (d) of the Act.
Each of IMS HEALTH and IMSHLA are responsible for the timely filing of the
statement and any amendments thereto and for the completeness and accuracy of
the information concerning each of them contained therein, but none is
responsible for the completeness or accuracy of the information concerning the
other.
IMS HEALTH INCORPORATED
By:/s/ MATTHEW L. FRIEDMAN
-----------------------------
Name: Matthew L. Friedman
Title: Vice President and Treasurer
IMS HEALTH LICENSING ASSOCIATES, L.P.
By /s/ PETER ECSHER
-------------------------------
Peter Escher,on behalf of
the General Partner,
IMS Pharminform Holding, AG
Page 7 of 7 Pages
